Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Novelion Therapeutics Inc (NVLNF)

Novelion Therapeutics Inc (NVLNF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Novelion Therapeutics Inc 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 CAN

www.novelion.com P: 617-500-7867

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

Novelion Therapeutics is a biopharmaceutical company. It engages in developing and marketing of ocular products for individuals living with rare diseases. The product portfolio includes MYALEPT(R) and JUXTAPID (R) and is also developing zuretinol and metrleptin. Novelion Therapeutics formerly known as QLT Inc. is headquatered in Vancouver, Canada.

Key Statistics

Overview:

Market Capitalization, $K 13,773
Shares Outstanding, K 19,619
Float, K 18,913
% Float 96.40%
% of Insider Shareholders 3.60%
% of Institutional Shareholders 48.64%

Financials:

Annual Sales, $ 130,430 K
Annual Net Income, $ -108,330 K

Growth:

1-Year Return -12.25%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -140.00%
5-Year Dividend Growth -100.00%

Per-Share Information:

Next Earnings Date 03/12/20
Earnings Per Share ttm -1.67
EPS Growth vs. Prev Qtr -62.14%
EPS Growth vs. Prev Year 5.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NVLNF Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -83.06%
Debt/Equity N/A
Price/Sales 0.43
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share 0.00
Interest Coverage -1.11
60-Month Beta 2.15
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar